Biotech Company 23andMe Will Use Its DNA Database for the Creation of New Treatments

March 13, 2015 8:57 AM

3 0

Founded in 2006, 23andMe is a genomics company which developed a saliva-based personal genome test, deemed the invention of the year in 2008 by the Time magazine. However, because the test had not received FDA approval, it was withdrawn in 2013. Now, the Google-backed company has announced its intention to search its very large DNA database in order to find possible connections between genetic information or mutations and the effectiveness of various treatments. Along with health information provided by patients, these facts might be correlated into comprehensive analyses which could yield precious clues for the development of new medication.

Pharma giants like Pfizer are also involved in this project – a dozen pharmaceutical companies have already agreed with 23andMe to use the genetic data in order to find hints about possible cures for specific diseases. Richard Scheller, who according to Wall Street Journal will be appointed chief sc...

Read more

To category page